Locations:
Search IconSearch

Research

DrScott_650x450
May 23, 2017/Cancer/Research

A New Strategy for Cancer Treatments

Moving from whack-a-mole to chess

abraham_650x450
May 8, 2017/Cancer/Research

Promising New Combination Therapy for Advanced, HER2+ Breast Cancer Shown Safe and Effective

Neratinib and trastuzumab emtansine (T-DM1) combination potent and well tolerated

maciejewski_650x450
March 15, 2017/Cancer/Research

Cleveland Clinic Researcher Receives $5.5 Million Outstanding Investigator Award

Maciejewski honored for work in bone marrow failure syndromes

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

kalady_650x450
February 27, 2017/Cancer/Research

Multigene Panel Testing Reveals Mutations in Early Onset CRC Patients

Results suggest: Offer broad testing to all of them

RCC_650x450
February 23, 2017/Cancer/Research

Sunitinib Treatment Breaks Feasible for Metastatic Renal Cell Carcinoma

Clinical efficacy uncompromised in previously untreated patients

BRCA1
February 6, 2017/Cancer/Research

Promise of PARP Inhibitors for BRCA1/BRCA2 Cancers

Clinical trials testing olaparib in breast cancer

Glioblastoma cells
January 16, 2017/Cancer/Research

Researchers Discover How Glioblastoma Stem Cells Evade the Immune System

Finding has potential to improve treatment

Picture2_650x450
September 12, 2016/Cancer/Research

Study Shows Active Surveillance is Safe and Viable in Some Metastatic Renal Cell Carcinoma Patients

Survival for months or several years while delaying treatment is possible

Figure-1_690x380
June 22, 2015/Cancer/Research

A Potential New Treatment for Aggressive Lymphomas

More efficient, safer therapy may be on horizon

BackPage 26 of 27Next

Advertisement

Ad